Green Thumb Industries Inc.

Green Thumb Industries Inc. Earnings Recaps

GTII.CN Health Care 1 recap
Next earnings: November 4, 2026 (estimated) · full calendar
Q2 2026 Aug 6, 2026

Green Thumb shares fell 7.7% following the earnings release, reflecting investor disappointment with modest revenue growth and ongoing price compression despite stable EBITDA margins and operational cash flow.

Key takeaways
  • Q2 revenue reached $307 million, up only 5% year-over-year, indicating ongoing deceleration amid a competitive and price-compressed market.
  • Normalized EBITDA was $84 million, representing about 28% of revenue, showing margin stability despite external pressures.
  • Operating cash flow was $29 million, signaling positive but limited cash generation relative to revenue growth.
  • Management highlighted progress on federal cannabis rescheduling and state regulatory advances, yet the company remains cautious on near-term growth dynamics.
  • Green Thumb repurchased approximately 8 million shares during the quarter at an average price just over $6, reducing share count by 13% since Q4 2023, signaling confidence in long-term value despite near-term headwinds.